Back to search results

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

Abroad (travel likely)RecruitingPHASE3

Conditions

Polycythemia Vera

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Regis Clinical Research LLC., Miami, Florida, United States

    Contact: Study coordinator (Roberto Reyes) · rreyes@regisclinical.com · 305-546-3952
    Contact: Principal Investigator (Yilena Rodriguez Marrero, MD)

  • Florida Clinical Trials Group, Plantation, Florida, United States

    Study coordinator · harshamin@floridactg.com · (772) 297-3057
    Contact: Principal Investigator (Harshad Amin, MD)

  • Florida Clinical Trials Group, Tamarac, Florida, United States

    Contact: Study coordinator (Maria Abreu) · abreum@floridactg.com · (772) 297-3057
    Contact: Principal Investigator (Chintan Gandhi, MD)

  • The Center for Cancer & Blood Disorders, Bethesda, Maryland, United States

    Contact: Study coordinator (Taylor Stutzman) · Taylor.Stutzman@aoncology.com · 301-571-0019
    Contact: Principal Investigator (Victor M Priego, MD)

  • Montefiore Medical Center, The Bronx, New York, United States

    Contact: Study coordinator (Joty Rashid) · jorashid@montefiore.org · 718-219-8181
    Contact: Principal Investigator (Swati Goel, MD)

  • Gabrail Cancer Center Research, Canton, Ohio, United States

    Contact: Study coordinator (Carrie Smith) · csmith@gabrailcancercenter.com · 330-417-8231
    Contact: Principal Investigator (Nashat Y Gabrail, MD)
Study leads

  • Clinical Team

    Study Director

    Deciphera Pharmaceuticals, LLC

View source on ClinicalTrials.gov(opens in a new tab)